加拿大28PC蛋蛋大小计划

Since its founding in 1921, 加拿大28PC蛋蛋大小计划 has been an integral part of Cleveland Clinic’s mission. The founders believed it was not only important to treat patients, but also to investigate the causes of disease. A century later, Cleveland Clinic is at the forefront of scientific discovery. Our 加拿大28PC蛋蛋大小计划ers are leaders in growing fields transforming the way medicine is delivered, including precision medicine, genomics, population health and immuno-oncology.

Lab-based and translational 加拿大28PC蛋蛋大小计划ers work to uncover novel biological pathways that contribute to a host of diseases, including cancer, cardiovascular and metabolic diseases, brain and eye diseases, and diseases of the inflammation and immune systems. They work closely with clinical 加拿大28PC蛋蛋大小计划ers from all areas of Cleveland Clinic to translate basic biological 加拿大28PC蛋蛋大小计划 discoveries into new diagnostic tests and treatments—including medical devices and therapeutics—that will benefit patients worldwide.

Pictured: One of the first instances of ground-breaking 加拿大28PC蛋蛋大小计划 at Cleveland Clinic beginning during the 1920's. Otto Glasser, MD, invented a way of accurately measuring the radiation doses being given to patients during what was then called Roentgen ray therapy (radiotherapy for cancer). The groundbreaking device was called a dosimeter.